Cargando…
Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study
To define benchmark values for liver transplantation (LT) in patients with perihilar cholangiocarcinoma (PHC) enabling unbiased comparisons. BACKGROUND: Transplantation for PHC is used with reluctance in many centers and even contraindicated in several countries. Although benchmark values for LT are...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983747/ https://www.ncbi.nlm.nih.gov/pubmed/35894433 http://dx.doi.org/10.1097/SLA.0000000000005641 |
_version_ | 1784900611828875264 |
---|---|
author | Breuer, Eva Mueller, Matteo Doyle, Majella B. Yang, Liu Darwish Murad, Sarwa Anwar, Imran J. Merani, Shaheed Limkemann, Ashley Jeddou, Heithem Kim, Steven C. López-López, Victor Nassar, Ahmed Hoogwater, Frederik J.H. Vibert, Eric De Oliveira, Michelle L. Cherqui, Daniel Porte, Robert J. Magliocca, Joseph F. Fischer, Lutz Fondevila, Constantino Zieniewicz, Krzysztof Ramírez, Pablo Foley, David P. Boudjema, Karim Schenk, Austin D. Langnas, Alan N. Knechtle, Stuart Polak, Wojciech G. Taner, C. Burcin Chapman, William C. Rosen, Charles B. Gores, Gregory J. Dutkowski, Philipp Heimbach, Julie K. Clavien, Pierre-Alain |
author_facet | Breuer, Eva Mueller, Matteo Doyle, Majella B. Yang, Liu Darwish Murad, Sarwa Anwar, Imran J. Merani, Shaheed Limkemann, Ashley Jeddou, Heithem Kim, Steven C. López-López, Victor Nassar, Ahmed Hoogwater, Frederik J.H. Vibert, Eric De Oliveira, Michelle L. Cherqui, Daniel Porte, Robert J. Magliocca, Joseph F. Fischer, Lutz Fondevila, Constantino Zieniewicz, Krzysztof Ramírez, Pablo Foley, David P. Boudjema, Karim Schenk, Austin D. Langnas, Alan N. Knechtle, Stuart Polak, Wojciech G. Taner, C. Burcin Chapman, William C. Rosen, Charles B. Gores, Gregory J. Dutkowski, Philipp Heimbach, Julie K. Clavien, Pierre-Alain |
author_sort | Breuer, Eva |
collection | PubMed |
description | To define benchmark values for liver transplantation (LT) in patients with perihilar cholangiocarcinoma (PHC) enabling unbiased comparisons. BACKGROUND: Transplantation for PHC is used with reluctance in many centers and even contraindicated in several countries. Although benchmark values for LT are available, there is a lack of specific data on LT performed for PHC. METHODS: PHC patients considered for LT after Mayo-like protocol were analyzed in 17 reference centers in 2 continents over the recent 5-year period (2014–2018). The minimum follow-up was 1 year. Benchmark patients were defined as operated at high-volume centers (≥50 overall LT/year) after neoadjuvant chemoradiotherapy, with a tumor diameter <3 cm, negative lymph nodes, and with the absence of relevant comorbidities. Benchmark cutoff values were derived from the 75th to 25th percentiles of the median values of all benchmark centers. RESULTS: One hundred thirty-four consecutive patients underwent LT after completion of the neoadjuvant treatment. Of those, 89.6% qualified as benchmark cases. Benchmark cutoffs were 90-day mortality ≤5.2%; comprehensive complication index at 1 year of ≤33.7; grade ≥3 complication rates ≤66.7%. These values were better than benchmark values for other indications of LT. Five-year disease-free survival was largely superior compared with a matched group of nodal negative patients undergoing curative liver resection (n=106) (62% vs 32%, P<0.001). CONCLUSION: This multicenter benchmark study demonstrates that LT offers excellent outcomes with superior oncological results in early stage PHC patients, even in candidates for surgery. This provocative observation should lead to a change in available therapeutic algorithms for PHC. |
format | Online Article Text |
id | pubmed-9983747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99837472023-03-04 Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study Breuer, Eva Mueller, Matteo Doyle, Majella B. Yang, Liu Darwish Murad, Sarwa Anwar, Imran J. Merani, Shaheed Limkemann, Ashley Jeddou, Heithem Kim, Steven C. López-López, Victor Nassar, Ahmed Hoogwater, Frederik J.H. Vibert, Eric De Oliveira, Michelle L. Cherqui, Daniel Porte, Robert J. Magliocca, Joseph F. Fischer, Lutz Fondevila, Constantino Zieniewicz, Krzysztof Ramírez, Pablo Foley, David P. Boudjema, Karim Schenk, Austin D. Langnas, Alan N. Knechtle, Stuart Polak, Wojciech G. Taner, C. Burcin Chapman, William C. Rosen, Charles B. Gores, Gregory J. Dutkowski, Philipp Heimbach, Julie K. Clavien, Pierre-Alain Ann Surg ESA Paper To define benchmark values for liver transplantation (LT) in patients with perihilar cholangiocarcinoma (PHC) enabling unbiased comparisons. BACKGROUND: Transplantation for PHC is used with reluctance in many centers and even contraindicated in several countries. Although benchmark values for LT are available, there is a lack of specific data on LT performed for PHC. METHODS: PHC patients considered for LT after Mayo-like protocol were analyzed in 17 reference centers in 2 continents over the recent 5-year period (2014–2018). The minimum follow-up was 1 year. Benchmark patients were defined as operated at high-volume centers (≥50 overall LT/year) after neoadjuvant chemoradiotherapy, with a tumor diameter <3 cm, negative lymph nodes, and with the absence of relevant comorbidities. Benchmark cutoff values were derived from the 75th to 25th percentiles of the median values of all benchmark centers. RESULTS: One hundred thirty-four consecutive patients underwent LT after completion of the neoadjuvant treatment. Of those, 89.6% qualified as benchmark cases. Benchmark cutoffs were 90-day mortality ≤5.2%; comprehensive complication index at 1 year of ≤33.7; grade ≥3 complication rates ≤66.7%. These values were better than benchmark values for other indications of LT. Five-year disease-free survival was largely superior compared with a matched group of nodal negative patients undergoing curative liver resection (n=106) (62% vs 32%, P<0.001). CONCLUSION: This multicenter benchmark study demonstrates that LT offers excellent outcomes with superior oncological results in early stage PHC patients, even in candidates for surgery. This provocative observation should lead to a change in available therapeutic algorithms for PHC. Lippincott Williams & Wilkins 2022-11 2022-07-27 /pmc/articles/PMC9983747/ /pubmed/35894433 http://dx.doi.org/10.1097/SLA.0000000000005641 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | ESA Paper Breuer, Eva Mueller, Matteo Doyle, Majella B. Yang, Liu Darwish Murad, Sarwa Anwar, Imran J. Merani, Shaheed Limkemann, Ashley Jeddou, Heithem Kim, Steven C. López-López, Victor Nassar, Ahmed Hoogwater, Frederik J.H. Vibert, Eric De Oliveira, Michelle L. Cherqui, Daniel Porte, Robert J. Magliocca, Joseph F. Fischer, Lutz Fondevila, Constantino Zieniewicz, Krzysztof Ramírez, Pablo Foley, David P. Boudjema, Karim Schenk, Austin D. Langnas, Alan N. Knechtle, Stuart Polak, Wojciech G. Taner, C. Burcin Chapman, William C. Rosen, Charles B. Gores, Gregory J. Dutkowski, Philipp Heimbach, Julie K. Clavien, Pierre-Alain Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title | Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title_full | Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title_fullStr | Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title_full_unstemmed | Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title_short | Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study |
title_sort | liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? results from an international benchmark study |
topic | ESA Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983747/ https://www.ncbi.nlm.nih.gov/pubmed/35894433 http://dx.doi.org/10.1097/SLA.0000000000005641 |
work_keys_str_mv | AT breuereva livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT muellermatteo livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT doylemajellab livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT yangliu livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT darwishmuradsarwa livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT anwarimranj livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT meranishaheed livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT limkemannashley livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT jeddouheithem livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT kimstevenc livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT lopezlopezvictor livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT nassarahmed livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT hoogwaterfrederikjh livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT viberteric livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT deoliveiramichellel livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT cherquidaniel livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT porterobertj livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT maglioccajosephf livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT fischerlutz livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT fondevilaconstantino livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT zieniewiczkrzysztof livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT ramirezpablo livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT foleydavidp livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT boudjemakarim livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT schenkaustind livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT langnasalann livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT knechtlestuart livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT polakwojciechg livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT tanercburcin livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT chapmanwilliamc livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT rosencharlesb livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT goresgregoryj livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT dutkowskiphilipp livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT heimbachjuliek livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy AT clavienpierrealain livertransplantationasanewstandardofcareinpatientswithperihilarcholangiocarcinomaresultsfromaninternationalbenchmarkstudy |